Publications

Search our bibliography using the filters on the right-hand side.

Displaying 1 through 46 of 46 publications.

Ravelo A, Myers K, Brumble R, Bussberg C, Koffman B, Manzoor BS, Biondo J, Mansfield C. Understanding patient preferences for chronic lymphocytic leukemia treatments. Poster presented at the 64th ASH Annual Meeting and Exposition; December 12, 2022. New Orleans, LA.

Singer D, Sweeney C, Reynolds M, Poston S. Assessing awareness and implementation of Herpes Zoster vaccine recommendations by subspecialists in the United States. Poster presented at the American Society of Health System Pharmacists (ASHP) 2022 Conference; December 4, 2022. Las Vegas, NV.

Sluga-O'Callaghan M, Derrien Ansquer V, Frugier G, Houghton K. Evaluation of national approvals and data-collection durations in retrospective noninterventional medical record review studies conducted in the United States, Canada, Europe, and Asia. Poster presented at the ISPOR Europe 2022; November 6, 2022. Vienna, Austria. [abstract] Value Health. 2022 Dec 1; 25(12):S488-9. doi: 10.1016/j.jval.2022.09.2424

McLauchlan L, Lancaster K, Kearnes M, Mellor R, Ritter A. "It's professional but it's personal": participation, personal connection, and sustained disagreement in drug policy reform. Int J Drug Policy. 2022 Dec;110:103903. doi: 10.1016/j.drugpo.2022.103903

Herrera-Restrepo O, Ghaswalla P, Davis K, Sweeney C, Davenport E, Trofa A, Buck PM. Hepatitis A and Hepatitis B vaccination in adult patients at risk: a survey of US healthcare providers' attitudes and practices. Hum Vaccin Immunother. 2022 Nov 30;18(6):2123180. doi: 10.1080/21645515.2022.2123180

Herrera-Restrepo O, Davis K, Sweeney C, Davenport E, Ghaswalla P, Buck PO. Hepatitis A and B vaccination in adults at risk: a survey of US healthcare providers' attitudes and practices. Hum Vaccin Immunother. 2022 Nov 30;18(6):2123180. doi: 10.1080/21645515.2022.2123180

Janssens R, Lang T, Vallejo A, Galinsky J, Morgan K, Plate A, De Ronne C, Verschueren M, Schoefs E, Vanhellemont A, Delforge M, Schjesvold F, Cabezudo E, Vandebroek M, Stevens H, Simoens S, Huys I. What matters most to patients with multiple myeloma? a Pan-European patient preference study. Front Oncol. 2022 Nov 29;12:1027353. doi: 10.3389/fonc.2022.1027353

Shamarina D, Sluga-O'Callaghan M, Dave V, Davenport E, Curran D, Marijam A, Andani A. Knowledge and attitudes of European HCPs towards hepatitis A and B vaccination of adults at risk. Poster presented at the 15th European Public Health Conference 2022 (EPH); November 9, 2022. Berlin, Germany.

Shields GE, Wells A, Wright S, Vass C, Davies LM, Doherty P, Capobianco L. A discrete choice experiment to investigate preferences for psychological intervention in cardiac rehabilitation. BMJ Open. 2022 Nov 7;12(11):e062503. doi: 10.1136/bmjopen-2022-062503

Barrett L, Mellor R, Ritter A, McLauchlan L, Kearnes M. Navigating the grey: experiences of incremental cannabis reform in Australia. Drug Alcohol Rev. 2022 Nov;41(7):1621-9. doi: 10.1111/dar.13518

Hsu RK, Phoenix J, Sinclair GI, Gupta SK, Puga A, Nguyen K, Schubert CK, Merrill D, Richardson D, Nelson K, Reynolds M, Zografos L, Jean-Louis A, Garris C. US Healthcare Provider Perspectives on the initiation of cabotegravir and rilpivirine long-acting (CAB+RPV LA) in an observational real-world study (BEYOND). Poster presented at the IDWeek 2022 Conference; October 21, 2022. Washington, DC.

Li D, Tan A, Hernandez S, Reilly N, Bussberg C, Mansfield C. Predicting treatment choices for unresectable hepatocellular carcinoma (HCC): results from a patient preference study. Poster presented at the AASLD 2022 The Liver Meeting; November 4, 2022. Washington, DC. [abstract] Hepatology. 2022 Oct 21; 76(S1):S1312. doi: 10.1002/hep.32697

Armstrong A, Jayade S, Rege S, Joshi N, Patel V, Davidson D, Kalirai S, Wolin D, Boyle K, Patel D, Seigel L. Evaluating treatment choice among patients with moderate or severe psoriasis. Poster presented at the 2022 Fall Clincial Dermotology Conference; October 20, 2022. Las Vegas, NV.

Li D, Darden C, Osman N, Sayeed S, Jackson L, Garbinsky D, Chauhan A. Real-world clinical and patient-reported outcomes from the longitudinal telotristat ethyl treatment registry of patients with neuroendocrine tumors. Cancer Manag Res. 2022 Oct 17;14:3009-20. doi: 10.2147/CMAR.S386419

Poulos C, Boeri M, Coulter JR, Huang L, Schley K, Pugh SJ. Travelers' preferences for tick-borne encephalitis vaccination. Expert Rev Vaccines. 2022 Oct 1;21(10):1495-504. doi: 10.1080/14760584.2022.2108798

Huang MY, Smith A, Brister T, Counts N, Sweeney C, McSorley D, Suthoff E, Parikh S. Report from a national survey of depression treatment: patient experience on antidepressant medications for major depressive disorder. Poster presented at the AMCP Nexus 2022; October 11, 2022. National Harbor, MD. [abstract] J Manag Care Pharm. 2022 Oct; 28(10-a):S59-60.

Wright S, Dalal G, Vass C, Georgsson S, Payne K. How do women want to receive information about non-invasive prenatal testing? Evidence from a discrete choice experiment. Prenat Diagn. 2022 Oct;42(11):1377-89. doi: 10.1002/pd.6243

Karim S, Craig BM, Vass C, Groothuis-Oudshoorn CGM. Current practices for accounting for preference heterogeneity in health-related discrete choice experiments: a systematic review. Pharmacoeconomics. 2022 Oct 1;40(10):943-56. doi: 10.1007/s40273-022-01178-y

La E, Bunniran S, Garbinsky D, Reynolds M, Poston S, Harrington L. Respiratory syncytial virus knowledge, attitudes, and perceptions among older adults in the United States. Poster presented at the 12th International RSV Symposium; September 29, 2022. Belfast, Ireland.

Huang MY, Counts N, Smith A, Brister T, Sweeney C, McSorley D, Suthoff E, Parikh S. Perspectives on the unmet need in the treatment of major depressive disorder: results from a patient survey. Poster presented at the Psych Congress 2022; September 17, 2022. New Orleans, LA.

Mellor R, Kearnes M, Lancaster K, McLauchlan L, Ritter A. Established tables and emergent huddles: exploring the processes of participation associated with the policy changes to opioid pharmacotherapy treatment in Australia in the context of COVID-19. Contemp Drug Probl. 2022 Sep 8;49(4):385-404. doi: 10.1177/00914509221123001

Mansfield C, Bullok K, Fuhs JV, Tockhorn-Heidenreich A, Andrews JS, DiBenedetti D, Matthews BR, Darling JC, Sutphin J, Hauber B. The patient voice: exploring treatment preferences in participants with mild cognitive concerns to inform regulatory decision making. Patient. 2022 Sep;15(5):551-64. doi: 10.1007/s40271-022-00576-w

Vass CM, Boeri M, Poulos C, Turner AJ. Matching and weighting in stated preferences for health care. Journal of choice modelling. 2022 Sep;44. doi: 10.1016/j.jocm.2022.100367

Janssens R, Lang T, Vallejo A, Galinsky J, Morgan K, Plate A, Verschueren M, Schoefs E, Vanhellemont A, Delforge M, Hellem Schjesvold F, Cabezudo E, Vandebroek M, Stevens H, Simoens S, Huys I. Patient preferences for multiple myeloma treatment: a stated preference survey using discrete choice experiment and swing weighting. Poster presented at the ISPOR 2022 Conference; May 15, 2022. National Harbor, MD. [abstract] Value Health. 2022 Jul; 25(7):S298. doi: 10.1016/j.jval.2022.04.069

Sydenham RV, Jarbol DE, Hansen MP, Justesen US, Watson V, Pedersen LB. Prescribing antibiotics: factors driving decision-making in general practice. A discrete choice experiment. Soc Sci Med. 2022 Jul;305:115033. doi: 10.1016/j.socscimed.2022.115033

Myers KH, Poulos C, Pierce AM. Atopic dermatitis patients prefer skin clearance outcomes, topical therapy. Poster presented at the Society of Dermatology Physician Assistants Annual Summer Dermatology Conference; June 20, 2022. Austin, TX.

Dobra R, Davies JC, Elborn JS, Kee F, Boeri M. A discrete choice experiment to quantify the influence of trial features on patients' decisions to join cystic fibrosis clinical trials. Poster presented at the 45th European Cystic Fibrosis Society Conference; June 8, 2022. Rotterdam, The Netherlands.

Poulos C, Ng X, Mansfield C, Rosenberg S, Peay H, Lee J, Irony T, Ho M. Logical soundness in a discrete choice experiment study of benefit risk preferences. Presented at the ISPOR 2022 Conference; May 15, 2022. Washington, DC. [abstract] Value Health. 2022 Jun; 25(6 S1).

Buchanan J, Hill M, Vass CM, Hammond J, Riedijk S, Klapwijk JE, Harding E, Lou S, Vogel I, Hui L, Ingvoldstad-Malmgren C, Soller MJ, Ormond KE, Choolani M, Zheng Q, Chitty LS, Lewis C. Factors that impact on women's decision-making around prenatal genomic tests: an international discrete choice survey. Prenat Diagn. 2022 Jun;42(7):934-46. doi: 10.1002/pd.6159

Li D, Tan A, Hernandez S, Reilly N, Bussberg CJ, Mansfield C. Patient preferences for unresectable hepatocellular carcinoma (HCC) treatments: balancing overall survival and quality of life. Poster presented at the ESMO 24th World Congress on Gastrointestinal Cancer 2022; June 2022. Barcelona, Spain. [abstract] Ann Oncol. 2022 Jun; 33(Suppl 4):s293.

Bridges JFP, Poulos C, Andrew Finkelstein E. Measuring health preferences of multiple stakeholders: issues and challenges. Presented at the ISPOR 2022 Conference; May 2022. Washington, DC.

Vass CM, Boeri M, Karim S, Marshall D, Craig B, Ho KA, Mott D, Ngorsuraches S, Badawy SM, Mühlbacher A, Gonzalez JM, Heidenreich S. Accounting for preference heterogeneity in discrete-choice experiments: an ISPOR Special Interest Group Report. Value Health. 2022 May;25(5):685-94.

Batliner K, Schwab P, Garcia B, Liu W, Ellis J, Racsa P. Descriptions of patients with hypertrophic cardiomyopathy. Poster presented at the 2022 AMCP Managed Care & Specialty Pharmacy Annual Meeting; April 13, 2022.

Ogdie A, Myers K, Mansfield C, Tillett W, Nash P, Leach C, Nowell WB, Gavigan K, Zueger P, McDearmon-Blondell E, Walsh J. Experiences and treatment preferences in patients with psoriatic arthritis: a cross-sectional study in the ArthritisPower registry. Rheum Ther. 2022 Apr;9(2):735-51. doi: 10.1007/s40744-022-00436-x

Patel S, Vaccaro J, Garcia B, Schwab P, Ellis J. Disease characterization of herpes zoster (shingles) in a Medicare advantage population with and without vaccine administration. Poster presented at the 2022 AMCP Managed Care & Specialty Pharmacy Annual Meeting; March 29, 2022. Chicago, IL.

Loria-Rebolledo LE, Ryan M, Watson V, Genie MG, Sakowsky RA, Powell D, Paranjothy S. Public acceptability of non-pharmaceutical interventions to control a pandemic in the UK: a discrete choice experiment. BMJ Open. 2022 Mar 8;12(3):e054155. doi: 10.1136/bmjopen-2021-054155

Zografos L, Wolin D, Andrews E, Calingaert B, Balabanova Y, Horvat-Brocker A, Tarenz C, Suzart-Woischnik K. Evaluating patient and physician knowledge of risks and safe use of rivaroxaban: a survey across four countries. Expert Opin Drug Saf. 2022 Mar;21(3):435-46. doi: 10.1080/14740338.2022.1998451

Hu A, Kwon M, Chung L, Rastegar J, Stevens L, Schwab P. HIV prep adherence on incidence of HIV diagnosis in a national health plan population. Poster presented at the 2022 AMCP Managed Care & Specialty Pharmacy Annual Meeting; March 29, 2022. Chicago, IL. [abstract] J Manag Care Pharm. 2022 Mar; 28(3-a):S88.

Alpert C, Rhodes C, Stevens L, Ellis JJ, Johnson S, Schwab P. Evaluation of pharmacist-led interventions for patients flagged for high morphine milligram equivalents (MME). Poster presented at the 2022 AMCP Managed Care & Specialty Pharmacy Annual Meeting; March 29, 2022. Chicago, IL. [abstract] J Manag Care Pharm. 2022 Mar; 28(3-a):S93.

Patel SM, Schwab P, Garcia B, Ellis JJ, Vaccaro J. Description of vaccination status and incidence of shingles. Poster presented at the 2022 AMCP Managed Care & Specialty Pharmacy Annual Meeting; March 29, 2022. Chicago, IL. [abstract] J Manag Care Pharm. 2022 Mar; 28(3-a):S88.

Huang I, Schwab P, Wojcicki S, Poonawalla I, Ellis JJ, Racsa P. Febrile neutropenia risk and health care costs in members receiving low-risk antineoplastic regimens with and without granulocyte colony stimulating factor primary prophylaxis support. Poster presented at the 2022 AMCP Managed Care & Specialty Pharmacy Annual Meeting; March 29, 2022. Chicago, IL. [abstract] J Manag Care Pharm. 2022 Mar; 28(3-a):S88.

Sanders C, Schwab P, Poonawalla I, Grebe L, Sassack K, Kennedy K, Vaccaro J, Ellis J. A real-world characterization of adverse drug events of Bruton tyrosine kinase inhibitors. Poster presented at the 2021 AMCP Managed Care & Specialty Pharmacy Annual Meeting; April 13, 2022. [abstract] J Manag Care Pharm. 2022 Mar; 28(3-a).

Herrera-Restrepo O, Ghaswalla P, Davis K, Sweeney C, Davenport E, Andani A, Buck PO. What can Europe learn from HCP knowledge and attitudes towards hepatitis A vaccination in the US? Poster presented at the Virtual 2022 EASLViral Hepatitis Elimination Conference; February 24, 2022. Previously presented at the 14th European Public Health Virtual Conference 2021 (EPH).

Ghaswalla P, Davis K, Sweeney C, Davenport E, Trofa A, Herrera-Restrepo O, Buck PO. Health care providers' knowledge, practices, and barriers to hepatitis vaccination guidelines. J Nurse Pract. 2022 Feb 16;18:403-10.

Dorgali MV, Longo A, Vass C, Shields G, Harrison R, Scarpa R, Boeri M. A general public study on preferences and welfare impacts of antimicrobial resistance in the United Kingdom. Pharmacoeconomics. 2022 Jan;40(1):65-76. doi: 10.1007/s40273-021-01076-9

Vass CM, Barton A, Payne K. Towards personalising the use of biologics in rheumatoid arthritis: a discrete choice experiment. Patient. 2022 Jan;15(1):109-19. doi: 10.1007/s40271-021-00533-z